Cannabis and Hemp Industry Investment News
Along with Priceline, more than 2100 independent pharmacies will also be able to access Medlab’s nutraceutical range. The cannabis drug developer aims...
The Denmark based Green Organic Dutchman and Knud Jepsen cannabis production joint venture will initially consist of a 37,500 square feet phase one pr...
() intends to transition from research & development (R&D) to a commercialisation phase as it prepares the trial design for a phase 2A study o...
What are you searching for? viewNamaste Technologies Inc Namaste Technologies () CEO Sean Dollinger sat down with Steve Darling from Proactive Investo...
The company said Greece's central European location allows export to other European countries with dramatically reduced shipping costs () (OTCQX:TGODF...
Namaste owns 10% of Cannbit and has a collaboration and supply agreement to purchase medical cannabis from the Israeli company Namaste hopes to rely o...
Proceeds will be used for construction of an automated greenhouse cannabis production facility in Australia The company specializes in organic medical...
A production joint venture (JV) and a genetics JV will be set up in Denmark by the two cannabis companies and the goal is to expand production to othe...
The facility will support the development of existing and new cannabinoid formulations. AusCann holds the full set of necessary licences to grow and m...
What are you searching for? viewMota Ventures The Vancouver-based exploration and development company will uplist to the OTCQB and continue to trade u...
The buyer said in a statement that the deal creates synergies with its existing Balkan-based medical cannabis and cannabidiol license portfolio
TGOD Acquisition Corporation is an investment firm mainly focused on investments in the cannabis industry The Ontario Superior Court of Justice has ap...
The company will capitalize on the need for indoor-grown, pharmaceutical-grade cannabis “HUGE” is the Canadian stock ticker for Inc () (OTCQB: FSDDF) ...
() is commercialising a therapeutics pipeline with four strategic pillars as the cannabis drug developer aims to help patients with diagnosed chronic ...
DayaCann is a 50:50 joint venture formed by AusCann and Chilean partner Fundación Daya. Khiron will pay DayaCann US$1.2 million () through its DayaCan...
